about
Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use (Review)The European medicines agency review of pomalidomide in combination with low-dose dexamethasone for the treatment of adult patients with multiple myeloma: summary of the scientific assessment of the committee for medicinal products for human useSurvival of non-transplant patients with multiple myeloma in routine care differs from that in clinical trials-data from the prospective German Tumour Registry Lymphatic Neoplasms
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Innovative agents in multiple myeloma
@ast
Innovative agents in multiple myeloma
@en
Innovative agents in multiple myeloma
@nl
type
label
Innovative agents in multiple myeloma
@ast
Innovative agents in multiple myeloma
@en
Innovative agents in multiple myeloma
@nl
prefLabel
Innovative agents in multiple myeloma
@ast
Innovative agents in multiple myeloma
@en
Innovative agents in multiple myeloma
@nl
P2860
P1476
Innovative agents in multiple myeloma
@en
P2093
P2860
P304
P356
10.6004/JADPRO.2014.5.3.4
P407
P577
2014-05-01T00:00:00Z